{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:15:06Z","timestamp":1783358106743,"version":"3.54.6"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clinme.2026.100584","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:26:20Z","timestamp":1776468380000},"page":"100584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypertension and heart failure: Navigating blood pressure targets and medication titration and tolerance"],"prefix":"10.1016","volume":"26","author":[{"given":"Irfan","family":"Helmy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8089-8073","authenticated-orcid":false,"given":"Mohamad","family":"Karnib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6543-8482","authenticated-orcid":false,"given":"Varun","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clinme.2026.100584_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11906-014-0447-7","article-title":"Hypertension as a risk factor for heart failure","volume":"16","author":"Kannan","year":"2014","journal-title":"Curr Hypertens Rep"},{"issue":"10","key":"10.1016\/j.clinme.2026.100584_bib2","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1161\/HYP.0000000000000249","volume":"82","author":"Writing Committee Members*","year":"2025","journal-title":"Hypertension"},{"issue":"10022","key":"10.1016\/j.clinme.2026.100584_bib3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.clinme.2026.100584_bib4","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"SPRINT Research Group","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinme.2026.100584_bib5","unstructured":"2024 ESC guidelines for the management of elevated blood pressure and hypertension.\u00a0Eur\u00a0Heart J. Oxford Academic.\u00a0\u3008https:\/\/academic.oup.com\/eurheartj\/article\/45\/38\/3912\/7741010?login=true\u3009\u00a0Accessed December 7, 2025."},{"key":"10.1016\/j.clinme.2026.100584_bib6","unstructured":"Recommendations.\u00a0Hypertension in adults: diagnosis and management.\u00a0Guidance.\u00a0NICE; 2019. \u3008https:\/\/www.nice.org.uk\/guidance\/ng136\/chapter\/Recommendations\u3009\u00a0Accessed December 7, 2025."},{"issue":"36","key":"10.1016\/j.clinme.2026.100584_bib7","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.clinme.2026.100584_bib8","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.clinme.2026.100584_bib9","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jchf.2024.03.001","article-title":"Eligibility and projected benefits of rapid initiation of quadruple therapy for newly diagnosed heart failure","volume":"12","author":"Greene","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"21","key":"10.1016\/j.clinme.2026.100584_bib10","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.clinme.2026.100584_bib11","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinme.2026.100584_bib12","unstructured":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure. N Engl J Med. \u3008https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1409077\u3009\u00a0Accessed December 11, 2025."},{"issue":"5","key":"10.1016\/j.clinme.2026.100584_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"SOLVD Investigators","year":"1991","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.clinme.2026.100584_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.clinme.2026.100584_bib15","first-page":"1651","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N\u00a0Engl\u00a0J\u00a0Med"},{"issue":"16","key":"10.1016\/j.clinme.2026.100584_bib16","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.clinme.2026.100584_bib17","first-page":"1609","article-title":"Angiotensin\u2013neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N\u00a0Engl\u00a0J\u00a0Med"},{"issue":"15","key":"10.1016\/j.clinme.2026.100584_bib18","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.clinme.2026.100584_bib19","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/ejhf.2206","article-title":"Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology","volume":"23","author":"Rosano","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.clinme.2026.100584_bib20","unstructured":"Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC - Skouri - 2025. Eur\u00a0J\u00a0Heart Fail. Wiley Online Library.\u00a0\u3008https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ejhf.3618\u3009\u00a0Accessed December 10, 2025."},{"issue":"6","key":"10.1016\/j.clinme.2026.100584_bib21","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s10741-025-10551-w","article-title":"Hypertensive acute heart failure: a critical perspective on definition, epidemiology, pathophysiology, and prognosis\u2014a narrative review: a joint session with the Romanian Society of Cardiology (part II)","volume":"30","author":"Geavlete","year":"2025","journal-title":"Heart Fail Rev"},{"issue":"18","key":"10.1016\/j.clinme.2026.100584_bib22","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","article-title":"2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.clinme.2026.100584_bib23","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/ejhf.3673","article-title":"Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"27","author":"Chioncel","year":"2025","journal-title":"Eur J Heart Fail"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211826000333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211826000333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:21:57Z","timestamp":1783354917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211826000333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1470211826000333"],"URL":"https:\/\/doi.org\/10.1016\/j.clinme.2026.100584","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertension and heart failure: Navigating blood pressure targets and medication titration and tolerance","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinme.2026.100584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of Royal College of Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100584"}}